Geoffrey Seidel

1.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Geoffrey Seidel is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Geoffrey Seidel has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Geoffrey Seidel's work include Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Geoffrey Seidel is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Geoffrey Seidel collaborates with scholars based in United States, United Kingdom and China. Geoffrey Seidel's co-authors include Steven K. Libutti, H. Richard Alexander, Nadira Yuldasheva, Giulio F. Paciotti, Adriana A. Byrnes, Melissa Walker, William E. Gannon, Lawrence Tamarkin, James F. Pingpank and Michelle Eugeni and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Geoffrey Seidel

14 papers receiving 975 citations

Hit Papers

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel ... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
    2010 540 citations Steven K. Libutti, Giulio F. Paciotti et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Seidel United States 8 392 383 223 221 165 14 1.0k
Tamer Refaat United States 12 484 1.2× 516 1.3× 142 0.6× 395 1.8× 34 0.2× 42 1.1k
Sang Geol Kim South Korea 15 187 0.5× 92 0.2× 635 2.8× 292 1.3× 255 1.5× 40 1.2k
Leslie Tupchong United States 15 545 1.4× 309 0.8× 302 1.4× 334 1.5× 74 0.4× 28 1.7k
Jin Woo Choi South Korea 19 332 0.8× 175 0.5× 69 0.3× 82 0.4× 265 1.6× 75 1.3k
Daphne M. Glass United Kingdom 13 266 0.7× 298 0.8× 522 2.3× 203 0.9× 145 0.9× 30 1.3k
Nathalie Siauve France 27 218 0.6× 130 0.3× 309 1.4× 169 0.8× 133 0.8× 78 1.9k
Chunxia Qin China 22 313 0.8× 149 0.4× 623 2.8× 318 1.4× 65 0.4× 77 1.5k
Damian A. Laber United States 16 176 0.4× 154 0.4× 292 1.3× 1.1k 5.2× 111 0.7× 76 1.8k
Jung Shin Lee South Korea 23 276 0.7× 197 0.5× 554 2.5× 590 2.7× 105 0.6× 86 1.8k
Yoko Yamamoto Japan 20 119 0.3× 164 0.4× 243 1.1× 397 1.8× 76 0.5× 94 1.2k

Countries citing papers authored by Geoffrey Seidel

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Seidel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Seidel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Seidel more than expected).

Fields of papers citing papers by Geoffrey Seidel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Seidel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Seidel. The network helps show where Geoffrey Seidel may publish in the future.

Co-authorship network of co-authors of Geoffrey Seidel

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Seidel. A scholar is included among the top collaborators of Geoffrey Seidel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Seidel. Geoffrey Seidel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lough, Mary E. & Geoffrey Seidel. (2015). Legal and Clinical Issues in Genetics and Genomics. Clinical Nurse Specialist. 29(2). 68–70. 1 indexed citations
2.
Wood, Bradford J., Ronnie T. P. Poon, Julia K. Locklin, et al.. (2011). Phase I Study of Heat-Deployed Liposomal Doxorubicin during Radiofrequency Ablation for Hepatic Malignancies. Journal of Vascular and Interventional Radiology. 23(2). 248–255.e7. 101 indexed citations
3.
Citrin, Deborah E., Kevin Camphausen, Bradford J. Wood, et al.. (2010). A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer. Oncology. 79(5-6). 382–388. 21 indexed citations
4.
Libutti, Steven K., Giulio F. Paciotti, Adriana A. Byrnes, et al.. (2010). Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine. Clinical Cancer Research. 16(24). 6139–6149. 540 indexed citations breakdown →
5.
Zeldis, Jerome B., Geoffrey Seidel, Nadira Yuldasheva, et al.. (2009). A randomized phase II trial comparing two doses of lenalidomide for the treatment of stage IV ocular melanoma. Journal of Clinical Oncology. 27(15_suppl). e20012–e20012. 6 indexed citations
6.
Powell, Anathea C., H. Richard Alexander, James F. Pingpank, et al.. (2008). The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery. 144(6). 878–884. 34 indexed citations
7.
Blansfield, Joseph, Shane Y. Morita, Peter L. Choyke, et al.. (2007). Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs). Surgery. 142(6). 814–818.e2. 172 indexed citations
8.
Citrin, Deborah E., Geoffrey Seidel, Martha Quezado, et al.. (2007). Early Results of a Pilot Study of Intra-tumoral Injection of TNFerade TM Biologic Concurrent With Neoadjuvant Chemoradiation Therapy for the Treatment of Primary and Recurrent Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 69(3). S303–S304. 1 indexed citations
9.
Camphausen, Kevin, Martha Quezado, Deborah E. Citrin, et al.. (2007). A pilot study of local injection of TNFerade biologic in addition to neo-adjuvant chemoradiation for the treatment of primary and recurrent rectal cancer. Journal of Clinical Oncology. 25(18_suppl). 14585–14585. 2 indexed citations
10.
Seidel, Geoffrey, et al.. (2006). Part II: Nursing Implications of Administering Chemotherapy in Interventional Radiology or the Operating Room. Clinical journal of oncology nursing. 10(3). 345–356. 1 indexed citations
11.
Seidel, Geoffrey, et al.. (2006). Part I: Regional Chemotherapy Clinical Studies in Nontraditional Clinical Settings. Clinical journal of oncology nursing. 10(3). 338–344. 2 indexed citations
12.
Pingpank, James F., Steven K. Libutti, Richard Chang, et al.. (2005). Phase I Study of Hepatic Arterial Melphalan Infusion and Hepatic Venous Hemofiltration Using Percutaneously Placed Catheters in Patients With Unresectable Hepatic Malignancies. Journal of Clinical Oncology. 23(15). 3465–3474. 89 indexed citations
13.
Seidel, Geoffrey, et al.. (1990). Nursing home autopsies. Survey of physician attitudes and practice patterns.. PubMed. 114(2). 145–7. 19 indexed citations
14.
Bilek, K, et al.. (1982). Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study.. PubMed. 52(3). 223–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamer Refaat Breakdown of academic impact, for papers by Sang Geol Kim Breakdown of academic impact, for papers by Leslie Tupchong Breakdown of academic impact, for papers by Jin Woo Choi Breakdown of academic impact, for papers by Daphne M. Glass Breakdown of academic impact, for papers by Nathalie Siauve Breakdown of academic impact, for papers by Chunxia Qin Breakdown of academic impact, for papers by Damian A. Laber Breakdown of academic impact, for papers by Jung Shin Lee Breakdown of academic impact, for papers by Yoko Yamamoto
Rankless by CCL
2026